Justification
Redacted Justification and Approval for Other Than Full and Open Competition Sequencing System for HIV-1 Genotype Testing
HT942626PE042
Defense Health Agency (Dha), Army Med Res Acq Activity. In-Vitro Diagnostic Substance Manufacturing.
Status
Justification
Posted October 1, 2026. Scheduled to archive November 15, 2026.
Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities
This one is not taking offers
13 like it are open now in in-vitro diagnostic substance manufacturing
- Reagents and consumables for Roche immunostainers
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00026Closes in 16 daysNov 16 - NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes in 2 daysNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes in 2 daysNov 2
Description
As published on SAM.gov.
The attached document is the Redacted Justification and Approval for the Other than Full anbd Open Competition of theSequencing System for HIV-1 Testing for WRAIR.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- A.02. DHA JA FAR Part 13.5- RFO reference changes 7.30 - redacted HT942626PE042.pdf418 KB, October 1, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 1, 2026
Justification
SAM.gov, notice c3f18d001cc24e9888bebc4fc3ebdd5b
1 revisions on SAM
- October 1, 2026: publish, justification
Points of contact
- Brenda Menabrenda.i.mena.civ@health.mil
- Lance Nowelllance.l.nowell.civ@health.mil